Search

everythinglearnresearchcommunity

for

Search:↓

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

There are various treatment options for frontal fibrosing alopecia.

Fucoidan may help regrow hair and reduce inflammation in hair loss.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

A mutant FERONIA gene affects root hair growth at high temperatures.

Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

DFMO may help control hair growth and treat cancer.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.